Streetbeat News

Partnerships

RNLX

Renalytix has expanded the insurance coverage of KidneyIntelX in Texas by securing contracts with BlueCross and BlueShield of Texas (BCBSTX) and Parkland Community Health Plan (PCHP). This complements coverage already secured with several other Blue Cross Blue Shield plans across the country. The company believes that achieving payer coverage with these large state-wide plans is crucial for bringing the benefits of KidneyIntelX prognostic technology to large populations of adults with type 2 diabetes and early stage kidney disease.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 11:10 am

PDRO

Pedro's List is collaborating with Mexico-based Grupo Medios to develop a digital marketing strategy in preparation for the launch of its app.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 9:04 am

AMZN

RIVN

Tech YouTuber Marques Brownlee has given a positive review of the electric delivery vans (EDV) manufactured by Rivian Automotive for Amazon. The EDVs are customized for delivery purposes and are available in two sizes. Rivian has started delivering the vans to Amazon in 2022 and they are now in operation across 800 cities in the U.S. and Europe. Amazon placed an order for 100,000 EDVs from Rivian in 2019.

Portfolio Pulse from Anan Ashraf

September 22, 2023 | 8:23 am

ALV

Autoliv, a leader in automotive safety systems, has announced a collaboration with Great Wall Motor to advance automotive safety technologies. The partnership aims to develop and integrate advanced safety systems into Great Wall Motor's vehicles.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 6:56 am

ORMP

SCLX

Oramed Pharmaceuticals has secured a $101.9M senior secured note deal with Scilex. The deal includes an 18-month maturity, an interest rate equal to the SOFR plus 8.5%, and a repayment commencement date of December 21, 2023. If the note is not fully repaid by March 21, 2024, an exit fee of $3,056,250 becomes payable. Oramed also has the right to designate an observer to Scilex's Board of Directors.

Portfolio Pulse from Benzinga Newsdesk

September 22, 2023 | 5:35 am

TSLA

Tata Motors-owned Jaguar has entered an agreement with Tesla to gain access to its over 12,000 superchargers in North America. The move is part of Jaguar's strategy to be all-electric by 2025. Jaguar will incorporate Tesla’s North American Charging Standard (NACS) connector design on its electric vehicles launching in 2025. Other automakers that have signed up for Tesla’s charging network include Ford Motor Co, General Motors, Rivian Automotive, and Mercedes-Benz.

Portfolio Pulse from Anan Ashraf

September 22, 2023 | 4:42 am

JPM

Ukrainian President Volodymyr Zelenskyy met with several billionaires, including former Google CEO Eric Schmidt, Mike Bloomberg, Robert Kraft, Barry Sternlicht, Bill Ackman, and former Secretary of State Henry Kissinger, to discuss financing for rebuilding Ukraine and its economy. The meeting was reportedly organized by JPMorgan Chase & Co. No details on any financial commitments were disclosed. JPMorgan has previously expressed interest in Ukraine's reconstruction and signed a memorandum of understanding with the country in February.

Portfolio Pulse from Chris Katje

September 21, 2023 | 11:26 pm

OLP

One Liberty Properties Inc has entered into an equity distribution agreement with B. Riley Securities, Inc. The agreement relates to the offer and sale of shares of common stock of up to $50M from time to time through or to the sales agent.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 8:55 pm

FLHLF

JAGX

Magdalena Biosciences, Jaguar Health (NASDAQ:JAGX) and Filament Health (OTCQB:FLHLF) have formed a joint venture to develop plant-based medicines for mental health indications. They have imported Peruvian coca leaf to Canada for research into potential treatments for adult ADHD. The coca leaves were authorized for import by the Peruvian Health Authority and will be used in Filament’s facility, Psilo Scientific, for initial research purposes.

Portfolio Pulse from Lara Goldstein

September 21, 2023 | 8:46 pm

ZYME

Zymeworks' unit, Beigene, has entered into the 3rd amendment to its license and collaboration deal on September 18, 2023. The unit is now eligible to receive tiered royalties ranging from high single-digit percentages up to 19.5% on net sales.

Portfolio Pulse from Benzinga Newsdesk

September 21, 2023 | 8:42 pm